Lethal nature of ischemic gastropathy

Area of Science:

• Gastroenterology
• Vascular Surgery
• Internal Medicine

Background:

• Gastropathy from mesenteric arterial ischemia is often misdiagnosed as gastritis, gastric ulceration, or gastric atony.
• These common conditions are typically linked to stress, H. pylori, or medications, while gastric atony is associated with diabetes or obstruction.
• Gastric ischemia is an underappreciated cause of gastropathy with a poor prognosis, necessitating early diagnosis for intervention.

Purpose of the Study:

• To describe the clinical presentation, diagnosis, and outcomes of patients with ischemic gastropathy.
• To highlight the importance of considering gastric ischemia in the differential diagnosis of unexplained gastropathy.
• To evaluate treatment strategies and their impact on survival in patients with ischemic gastropathy.

Main Methods:

• Case series describing seven female patients (aged 41-71) with ischemic gastropathy.
• Patients were smokers with hypertension and presented with nausea, vomiting, weight loss, and gastrointestinal bleeding.
• Diagnosis was confirmed via endoscopic or autopsy findings of gastric ulcerations, necrosis, or gastroparesis.

Main Results:

• Four out of five patients with ischemic gastritis died within 3 months despite vascular reconstruction.
• Two patients with gastroparesis secondary to ischemia showed positive outcomes after aorto-celiac bypass, remaining well at 9 and 20 months.
• Treatment outcomes were poor for gastritis, but better for gastroparesis, underscoring the importance of accurate diagnosis.

Conclusions:

• Ischemic gastropathy is an underdiagnosed entity that can present similarly to more common gastrointestinal issues.
• Early diagnosis and prompt treatment, particularly vascular intervention for gastroparesis, may improve survival rates.
• Further research is needed to improve the recognition and management of gastric ischemia to reduce high mortality rates.